MedTrace Logo

Dendritic Cells-Derived Exosomes in Human Sepsis

NCT02957279 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-11-07

No results posted yet for this study

Summary

The amount of peripheral blood exosomes has been confirmed to change in the endotoxin-induced infection. The primary objectives of this study are to compare the changes of peripheral blood dendritic cell-derived exosomes in the patients with sepsis and the healthy controls.

Conditions

Interventions

DRUG

Antibiotics

In the sepsis group, antibiotics were used when needed.

Sponsors & Collaborators

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Jianan Ren, MD · Jinling Hospital, Medical School of Nanjing University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-09-30
Completion
2017-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02957279 on ClinicalTrials.gov